CLICK HERE to view a copy of the presentation made by Pravin Dugel MD on 12 October 2019 at the American Academy of Ophthalmology Annual Meeting (AAO) in San Francisco relating to the Company’s Phase 1/2a clinical trial of its hRPC stem cell therapy in retinitis pigmentosa (RP).
To view the presentation being made at the AGM on 12 September at 10.00am please click here.
To view the presentation of the preliminary results for the year ended 31 March 2019 please click here.
A recording of the webcast can be accessed via the following link:
ReNeuron will be presenting at the H.C. Wainwright & Co. global life sciences conference in London on April 9th, 2019.
Details of the conference can be found on our Events page.
The ReNeuron presentation can be accessed by webcast on April 9, 2019 3:30 p.m. (BST)
Olav Hellebo, ReNeuron CEO will be presenting via webcast at the Alliance for Regenerative Medicine : Cell & Gene investor day on March 21, 2019.
ReNeuron’s slot is approximately 9.10am Eastern time (approx. 1.10 pm UK time)
To listen, please follow the link to access further information